>
pdufa.bio

ALT-803

Updated ยทnext FDA decision on the calendar

ALT-803 is a ImmunityBio, Inc. program. Every date links its source.

IBRX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: ImmunityBio, Inc. (IBRX). We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Sep 2026IBRX

Questions

When is ALT-803's next FDA decision or readout?

No upcoming catalyst is on our calendar for ALT-803; no FDA decisions are on record below.

What happened at ALT-803's most recent FDA decision?

No FDA decision for ALT-803 is in our archive yet.

Who makes ALT-803?

ImmunityBio, Inc. (IBRX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.